LL-37 is a member of the cathelicidin family of peptides, recognized for its broad-spectrum antimicrobial properties. Research indicates that LL-37 exhibits antibacterial, antiviral, and antifungal activity, and may play a role in modulating inflammatory responses. Emerging studies also suggest potential effects on tumor-related pathways and promotion of angiogenesis (blood vessel formation) in certain experimental settings.